Advanced Medical Solutions Group plc
AMS.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £177,521 | £126,210 | £124,330 | £108,601 |
| % Growth | 40.7% | 1.5% | 14.5% | – |
| Cost of Goods Sold | £84,903 | £56,070 | £55,709 | £52,486 |
| Gross Profit | £82,769 | £70,140 | £68,621 | £56,115 |
| % Margin | 46.6% | 55.6% | 55.2% | 51.7% |
| R&D Expenses | £5,237 | £5,597 | £4,323 | £3,841 |
| G&A Expenses | £69,033 | £50,669 | £47,378 | £36,970 |
| SG&A Expenses | £67,078 | £52,189 | £49,004 | £38,453 |
| Sales & Mktg Exp. | £2,348 | £1,520 | £1,626 | £1,483 |
| Other Operating Expenses | £9,084 | -£6,528 | -£4,801 | -£4,222 |
| Operating Expenses | £81,399 | £51,258 | £48,526 | £38,072 |
| Operating Income | £10,454 | £18,882 | £24,890 | £22,998 |
| % Margin | 5.9% | 15% | 20% | 21.2% |
| Other Income/Exp. Net | -£631 | £2,275 | £1,020 | -£1,014 |
| Pre-Tax Income | £9,823 | £21,157 | £25,910 | £21,984 |
| Tax Expense | £2,681 | £5,268 | £5,504 | £4,503 |
| Net Income | £7,094 | £15,889 | £20,406 | £17,481 |
| % Margin | 4% | 12.6% | 16.4% | 16.1% |
| EPS | 0.033 | 0.074 | 0.094 | 0.081 |
| % Growth | -55% | -21.9% | 16.3% | – |
| EPS Diluted | 0.033 | 0.073 | 0.093 | 0.08 |
| Weighted Avg Shares Out | 214,339 | 215,898 | 216,512 | 215,677 |
| Weighted Avg Shares Out Dil | 218,298 | 219,289 | 219,481 | 218,312 |
| Supplemental Information | – | – | – | – |
| Interest Income | £2,161 | £2,473 | £819 | £84 |
| Interest Expense | £3,557 | £384 | £638 | £1,098 |
| Depreciation & Amortization | £16,302 | £10,788 | £8,844 | £8,848 |
| EBITDA | £29,682 | £31,398 | £34,939 | £31,549 |
| % Margin | 16.7% | 24.9% | 28.1% | 29.1% |